In a Neutral regime, GSK's AIQ Score of 59/100 with Quality base of 81/100 and fading Momentum at 33/100 (Δ-28) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Quality (81/100) leads while Momentum (33/100) lags. This cross-factor spread creates entry timing uncertainty. Wait for the lagging factor to begin recovering before adding aggressively.
Quick Stats
GSK's 7-day signal profile is softening with AIQ change of -7.0 points and momentum delta of -28.0. Trend delta is -7.00, which helps frame whether the current move is accelerating or fading.
Snapshot: Sat, 25 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.
| Date | AIQ | Mom | Val | Qual | Risk |
|---|---|---|---|---|---|
| 2026-07-24 | 59 | 33 | 66 | 81 | 47 |
| 2026-07-23 | 58 | 27 | 66 | 81 | 46 |
| 2026-07-22 | 61 | 39 | 66 | 81 | 46 |
| 2026-07-21 | 60 | 35 | 66 | 81 | 45 |
| 2026-07-20 | 59 | 31 | 66 | 81 | 45 |
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
GSK (GSK) Stock Analysis
GSK (GSK) has an AIQ Score of 59/100 in a Neutral regime as of Jul 24, 2026. Quality is strongest at 81/100. Momentum is weakest at 33/100. The main conflict is that quality remains supportive at 81/100 while 7-day momentum is fading (-28.0 pts).
GSK (GSK) carries an AIQ Score of 59 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 0.32, implying roughly 68% lower sensitivity than a broad market baseline.
In the latest weekly profile, AIQ has moved -7.0 points over the last 7 days, momentum delta is -28.0, trend delta is -7.00, risk delta is +1.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | GSK is in a Neutral AIQ regime with score 59/100. |
| Signal Conflict | The primary conflict is that quality remains supportive at 81/100 while 7-day momentum is fading (-28.0 pts). |
| Factor Evidence | Momentum 33/100 · Value 66/100 · Quality 81/100 · Risk 47/100 |
| Persistence | GSK has scored AIQ 60+ in 51 of the last 60 daily snapshots. 30-day avg: 66/100. 60-day avg: 64/100. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Pass | Quality is the strongest factor at 81/100. |
| Timing | Fail | Momentum is 33/100 with 7-day delta -28.0. |
| Regime fit | Wait | GSK is in a Neutral regime at 59/100. |
| Risk control | Wait | Risk factor is 47/100 with beta of 0.32 implies lower sensitivity than the broader market. |
| Conflict | Wait | Current conflict: quality remains supportive at 81/100 while 7-day momentum is fading (-28.0 pts). |
GSK's 7-day signal profile is softening with AIQ change of -7.0 points and momentum delta of -28.0. Trend delta is -7.00, which helps frame whether the current move is accelerating or fading.
Signal snapshot as of Sat, 25 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.
| Metric | Current |
|---|---|
| AIQ Score | 59/100 |
| Price | $51.35 |
| Beta | 0.32 |
GSK vs Technology Peers
Portfolio Implication
Related Links
GSK Stock FAQ
What does the GSK AIQ Score mean?
AIQ Score summarizes multiple factors for GSK, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is GSK data updated?
GSK quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare GSK with an index before investing?
Yes. Comparing GSK versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper GSK fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading GSK...